Details for New Drug Application (NDA): 050593
✉ Email this page to a colleague
NDA 050593 describes ERYC SPRINKLES, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the ERYC SPRINKLES profile page.
The generic ingredient in ERYC SPRINKLES is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
The generic ingredient in ERYC SPRINKLES is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 050593
| Tradename: | ERYC SPRINKLES |
| Applicant: | Hospira |
| Ingredient: | erythromycin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050593
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | 125MG | ||||
| Approval Date: | Jul 22, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
